These data are aligned with prior evidence showing that the suppression of TWIST1 hampers the growth of primary skin papilloma induced by carcinogens36; and that the pharmacological inhibition of the Twist-BRD4-Wnt5a signaling axis results in the reduction of tumorigenicity of basal-like breast cancer37. Here, TWIST1 is linked to skin papilloma.